publication venue for
- In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. 1-14. 2024
- Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. 1-13. 2024
- Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood-Brain Barrier in Patients with Glioblastoma.. 1430-1442. 2023
- Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review. 1009-1027. 2022
- Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. 2565-2577. 2022
- Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. 182-197. 2022
- Synthesis of Dipyridylaminoperylenediimide¿Metal Complexes and Their Cytotoxicity Studies. 1-16. 2022
- An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products. 507-519. 2021
- Carotenoids from persimmon (Diospyros kaki Thunb.) byproducts exert photoprotective, antioxidative and microbial anti-adhesive effects on HaCaT. 1-16. 2021
- Controlled delivery formulations. 374-377. 2021
- Evaluation of the Predictive Performance of Population Pharmacokinetic Models of Adalimumab in Patients with Inflammatory Bowel Disease. 1244-1257. 2021
- L-Menthol-loadable electrospun fibers of PMVEMA anhydride for topical administration. 1845-1857. 2021
- Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study. 982-1009. 2021
- One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products. 690-709. 2021
- Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat.. 1402. 2021
- Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation. 1-5. 2021
- pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis.. 94. 2021
- Application of the Gastrointestinal Simulator (GIS) coupled with in silico modeling to measure the impact of Coca-Cola® on the luminal and systemic behavior of loratadine (BCS class 2b). 566-590. 2020
- Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019. 316-330. 2020
- Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs. 988-1002. 2020
- Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool. 633. 2020
- In vivo predictive dissolution (IPD) for Carbamazepine formulations: Additional evidence regarding the universal biopredictive dissolution medium. . 558-579. 2020
- Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP. 74-102. 2020
- Niosome-based approach for in situ gene delivery to retina and brain cortex as immune-privileged tissues. 1-29. 2020
- Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development. 295. 2020
- Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery. 1-23. 2019
- Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System. 567-583. 2019
- Development of a New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment. 1-14. 2019
- Development of new delivery system based on drug-loadable electrospun nanofibers for psoriasis treatment. 1-14. 2019
- Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses. 122-140. 2019
- Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products.. 663-673. 2019
- Long-Circulating Hyaluronan-Based Nanohydrogels as Carriers of Hydrophobic Drugs.. 213-228. 2018
- Ionic channels as targets for drug design: a review on computational methods. 1-11. 2011